等待開盤 11-26 09:30:00 美东时间
+5.020
+4.09%
Can-Fite BioPharma will attend BioFIT 2025 to seek partnerships for its Phase III cancer drug Namodenoson, targeting the $3.1 billion veterinary oncology market. The company also develops Piclidenoson for pet osteoarthritis, a $3 billion market. Can-Fite previously partnered with Vetbiolix for Piclidenoson, potential $325M in royalties. At BioFIT, Can-Fite will meet Elanco and Zoetis to explore Namodenoson collaborations, leveraging its strong an...
11-24 12:00
Elanco Animal Health (ELAN) has received Emergency Use Authorization from the U.S. FDA for its product, Credelio CAT, which is designed to treat New World screwworm infestations in cats. This authoriz...
11-22 04:14
KeyBanc initiates Zoetis at Sector Weight, citing OA drug headwinds, rising competition, and limited near-term catalysts despite strong fundamentals.
11-22 01:24
Keybanc analyst Steve Dechert initiates coverage on Zoetis (NYSE:ZTS) with a Sector Weight rating.
11-21 21:51
In the current market session, Zoetis Inc. (NYSE:ZTS) price is at $117.53, afte...
11-21 01:00
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
11-19 11:01
Stifel analyst Jonathan Block maintains Zoetis (NYSE:ZTS) with a Hold and lowers the price target from $140 to $130.
11-18 21:06
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
11-13 09:58
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
11-12 19:50
Zoetis Inc. today announced the acquisition of Veterinary Pathology Group (VPG), a leading veterinary diagnostic laboratory group with multiple locations across the UK and Ireland. The acquisition further expands Zoetis'
11-11 23:37